Haliloğlu G, Donkervoort S, Öztoprak Ülkühan, et al. Neurogenic arthrogryposis, hypotonia, dysmorphic features plus malformation of cortical development further expands the ARL6IP1 loss-of-function phenotype. Neuromuscular disorders : NMD. 2025;48:105312. doi:10.1016/j.nmd.2025.105312
Rodin RE, Walsh CA. Somatic Mutation in Pediatric Neurological Diseases. Pediatr Neurol. 2018;87:20-22. doi:10.1016/j.pediatrneurol.2018.08.008
Giera S, Deng Y, Luo R, et al. The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development. Nat Commun. 2015;6:6121. doi:10.1038/ncomms7121
Yuskaitis CJ, Jones BM, Wolfson RL, et al. A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility. Neurobiol Dis. 2018;111:91-101. doi:10.1016/j.nbd.2017.12.010
D’Gama AM, Woodworth MB, Hossain AA, et al. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias. Cell Rep. 2017;21(13):3754-3766. doi:10.1016/j.celrep.2017.11.106
Jamuar SS, Lam ATN, Kircher M, et al. Somatic mutations in cerebral cortical malformations. N Engl J Med. 2014;371(8):733-43. doi:10.1056/NEJMoa1314432
Andresen L, Hampton D, Taylor-Weiner A, et al. Gabapentin attenuates hyperexcitability in the freeze-lesion model of developmental cortical malformation. Neurobiol Dis. 2014;71:305-16. doi:10.1016/j.nbd.2014.08.022
D’Gama AM, Geng Y, Couto JA, et al. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol. 2015;77(4):720-5. doi:10.1002/ana.24357
Jamuar SS, Walsh CA. Genomic variants and variations in malformations of cortical development. Pediatr Clin North Am. 2015;62(3):571-85. doi:10.1016/j.pcl.2015.03.002
Whitman MC, Andrews C, Chan WM, et al. Two unique TUBB3 mutations cause both CFEOM3 and malformations of cortical development. Am J Med Genet A. 2016;170A(2):297-305. doi:10.1002/ajmg.a.37362